Arabella H Wan

Title(s)Postdoctoral Scholar - Research Associate
SchoolKeck School of Medicine of Usc
Address2011 Zonal Ave.
Health Sciences Campus
Los Angeles CA 90033
vCardDownload vCard

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Integrating genome-wide CRISPR screens and in silico drug profiling for targeted antidote development. Nat Protoc. 2024 Sep; 19(9):2739-2770. Wang B, Xu Y, Wan AH, Wan G, Wang QP. PMID: 38816517.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimals
    2. Galectin-7 Induction by EHMT2 Inhibition Enhances Immunity in Microsatellite Stability Colorectal Cancer. Gastroenterology. 2024 03; 166(3):466-482. Sun L, Liu R, Wu ZJ, Liu ZY, Wan AH, Yan S, Liu C, Liang H, Xiao M, You N, Lou Y, Deng Y, Bu X, Chen D, Huang J, Zhang X, Kuang DM, Wan G. PMID: 38065340.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    3. A multidimensional platform of patient-derived tumors identifies drug susceptibilities for clinical lenvatinib resistance. Acta Pharm Sin B. 2024 Jan; 14(1):223-240. Sun L, Wan AH, Yan S, Liu R, Li J, Zhou Z, Wu R, Chen D, Bu X, Ou J, Li K, Lu X, Wan G, Ke Z. PMID: 38261805; PMCID: PMC10793100.
      View in: PubMed   Mentions: 3  
    4. Biological informed graph neural network for tumor mutation burden prediction and immunotherapy-related pathway analysis in gastric cancer. Comput Struct Biotechnol J. 2023; 21:4540-4551. Liu C, Wan AH, Liang H, Sun L, Li J, Yang R, Li Q, Wu R, Hu K, Yang Y, Cai S, Wan G, He W. PMID: 37810279; PMCID: PMC10550590.
      View in: PubMed   Mentions:
    5. Identification of indocyanine green as a STT3B inhibitor against mushroom α-amanitin cytotoxicity. Nat Commun. 2023 05 16; 14(1):2241. Wang B, Wan AH, Xu Y, Zhang RX, Zhao BC, Zhao XY, Shi YC, Zhang X, Xue Y, Luo Y, Deng Y, Neely GG, Wan G, Wang QP. PMID: 37193694; PMCID: PMC10188588.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansAnimals
    6. N6-methyladenosine demethylase FTO enhances chemo-resistance in colorectal cancer through SIVA1-mediated apoptosis. Mol Ther. 2023 02 01; 31(2):517-534. Lin Z, Wan AH, Sun L, Liang H, Niu Y, Deng Y, Yan S, Wang QP, Bu X, Zhang X, Hu K, Wan G, He W. PMID: 36307991; PMCID: PMC9931553.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    7. RNA and RNA Derivatives: Light and Dark Sides in Cancer Immunotherapy. Antioxid Redox Signal. 2022 12; 37(16-18):1266-1290. Deng Y, Xiao M, Wan AH, Li J, Sun L, Liang H, Wang QP, Yin S, Bu X, Wan G. PMID: 35369726.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    8. Measurement of Circulating Tumor Cells to Track Hepatocellular Carcinoma Progression After Liver Transplantation-Case Report. Front Oncol. 2021; 11:760765. Deng Y, Sun L, Liang H, Cui B, Cui C, Zhao D, Wan A, Wan G. PMID: 34745999; PMCID: PMC8565924.
      View in: PubMed   Mentions: 2  
    9. Design and Discovery of Natural Cyclopeptide Skeleton Based Programmed Death Ligand 1 Inhibitor as Immune Modulator for Cancer Therapy. J Med Chem. 2020 10 08; 63(19):11286-11301. Sun H, Chen D, Zhan S, Wu W, Xu H, Luo C, Su H, Feng Y, Shao W, Wan A, Zhou B, Wan G, Bu X. PMID: 32844651.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    10. RNA m6 A methylation regulates sorafenib resistance in liver cancer through FOXO3-mediated autophagy. EMBO J. 2020 06 17; 39(12):e103181. Lin Z, Niu Y, Wan A, Chen D, Liang H, Chen X, Sun L, Zhan S, Chen L, Cheng C, Zhang X, Bu X, He W, Wan G. PMID: 32368828; PMCID: PMC7298296.
      View in: PubMed   Mentions: 204     Fields:    Translation:HumansAnimalsCells
    11. RNA N6-methyladenosine demethylase FTO promotes breast tumor progression through inhibiting BNIP3. Mol Cancer. 2019 03 28; 18(1):46. Niu Y, Lin Z, Wan A, Chen H, Liang H, Sun L, Wang Y, Li X, Xiong XF, Wei B, Wu X, Wan G. PMID: 30922314; PMCID: PMC6437932.
      View in: PubMed   Mentions: 278     Fields:    Translation:HumansAnimalsCells
    12. N6-Methyladenosine modification: a novel pharmacological target for anti-cancer drug development. Acta Pharm Sin B. 2018 Oct; 8(6):833-843. Niu Y, Wan A, Lin Z, Lu X, Wan G. PMID: 30505654; PMCID: PMC6251950.
      View in: PubMed   Mentions: 41  
    Arabella's Networks
    Concepts (69)
    Derived automatically from this person's publications.
    _
    Co-Authors (1)
    People in Profiles who have published with this person.
    _
    Similar People (60)
    People who share similar concepts with this person.
    _
    Same Department
    Search Department
    _